Short Interest in Valneva SE (NASDAQ:VALN) Expands By 191.4%

Valneva SE (NASDAQ:VALN - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 16,900 shares, an increase of 191.4% from the February 28th total of 5,800 shares. Based on an average daily volume of 57,400 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.0% of the shares of the stock are short sold.

Analyst Ratings Changes

Several brokerages recently issued reports on VALN. Guggenheim cut their price target on shares of Valneva from $17.00 to $15.00 and set a "buy" rating for the company in a report on Monday, March 24th. HC Wainwright reiterated a "buy" rating and issued a $17.00 target price on shares of Valneva in a research note on Friday, March 21st.

Valneva Price Performance

Shares of VALN stock traded up $0.01 during trading hours on Friday, hitting $7.26. 13,815 shares of the company's stock were exchanged, compared to its average volume of 26,249. Valneva has a 52 week low of $3.62 and a 52 week high of $9.50. The stock has a market cap of $589.95 million, a price-to-earnings ratio of -55.85 and a beta of 1.93. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.78 and a quick ratio of 2.25. The stock's 50-day moving average is $6.63 and its 200-day moving average is $5.59.

Valneva (NASDAQ:VALN - Get Free Report) last announced its earnings results on Thursday, March 20th. The company reported ($0.54) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by ($0.32). Valneva had a negative return on equity of 3.93% and a negative net margin of 4.35%. The company had revenue of $56.48 million during the quarter, compared to the consensus estimate of $55.64 million. As a group, research analysts forecast that Valneva will post 0.13 EPS for the current year.

Remove Ads

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Valneva stock. ABC Arbitrage SA acquired a new position in Valneva SE (NASDAQ:VALN - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 19,244 shares of the company's stock, valued at approximately $84,000. Institutional investors and hedge funds own 11.39% of the company's stock.

Valneva Company Profile

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; IXCHIQ, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus; and VLA2001, an inactivated whole-virus COVID-19 vaccine.